APG-115 Alone or in Combination With APG-2575 in Children With Recurrent or Refractory Neuroblastoma or Solid Tumors
Conditions: Neuroblastoma; Solid Tumor Interventions: Drug: APG-115; Drug: APG-2575 Sponsors: Ascentage Pharma Group Inc.; Suzhou Yasheng Pharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials